Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma

Journal of Experimental & Clinical Cancer Research · Published 2026-08-05 · DOI 10.1186/s13046-026-03793-5

Free full text

Authors (37)

Sophia Varriano, Amy Yu, Abantika Chakraborty, Ariana E. Nelson, Amy James, Kristine Isanogle, Nimit Patel, Caleb Kim, Unsun Lee, Victor J. Collins, Grace B. McKay-Corkum, Ye Yang, Xiaohu Zhang, Crystal McKnight, Kelli Wilson, Carleen Klumpp-Thomas, Michele Ceribelli, David Holland, Ming Sun, Gitanjali Asampille, Ying Wu, Krithika Bhuvaneshwar, Brad Gouker, Donna Butcher, Bhushan L. Thakur, Arnulfo Mendoza, Sameer H. Issaq, Mirit I. Aladjem, Baktiar O. Karim, Jack F. Shern, Parthav Jailwala, Simone Difilippantonio, Craig J. Thomas, Daniel R. Crooks, Rosa Nguyen, Carol J. Thiele, Christine M. Heske

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Varriano, S., Yu, A., Chakraborty, A., et al. (2026). Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-026-03793-5

Related articles